507 related articles for article (PubMed ID: 30128941)
21. Detection of Splicing Abnormalities and Genotype-Phenotype Correlation in X-linked Alport Syndrome.
Horinouchi T; Nozu K; Yamamura T; Minamikawa S; Omori T; Nakanishi K; Fujimura J; Ashida A; Kitamura M; Kawano M; Shimabukuro W; Kitabayashi C; Imafuku A; Tamagaki K; Kamei K; Okamoto K; Fujinaga S; Oka M; Igarashi T; Miyazono A; Sawanobori E; Fujimaru R; Nakanishi K; Shima Y; Matsuo M; Ye MJ; Nozu Y; Morisada N; Kaito H; Iijima K
J Am Soc Nephrol; 2018 Aug; 29(8):2244-2254. PubMed ID: 29959198
[TBL] [Abstract][Full Text] [Related]
22. COL4A3 mutation is an independent risk factor for poor prognosis in children with Alport syndrome.
Ozdemir G; Gulhan B; Atayar E; Saygılı S; Soylemezoglu O; Ozcakar ZB; Eroglu FK; Candan C; Demir BK; Soylu A; Yüksel S; Alpay H; Agbas A; Duzova A; Hayran M; Ozaltin F; Topaloglu R
Pediatr Nephrol; 2020 Oct; 35(10):1941-1952. PubMed ID: 32394188
[TBL] [Abstract][Full Text] [Related]
23. Guidelines for Genetic Testing and Management of Alport Syndrome.
Savige J; Lipska-Zietkiewicz BS; Watson E; Hertz JM; Deltas C; Mari F; Hilbert P; Plevova P; Byers P; Cerkauskaite A; Gregory M; Cerkauskiene R; Ljubanovic DG; Becherucci F; Errichiello C; Massella L; Aiello V; Lennon R; Hopkinson L; Koziell A; Lungu A; Rothe HM; Hoefele J; Zacchia M; Martic TN; Gupta A; van Eerde A; Gear S; Landini S; Palazzo V; Al-Rabadi L; Claes K; Corveleyn A; Van Hoof E; van Geel M; Williams M; Ashton E; Belge H; Ars E; Bierzynska A; Gangemi C; Renieri A; Storey H; Flinter F
Clin J Am Soc Nephrol; 2022 Jan; 17(1):143-154. PubMed ID: 34930753
[TBL] [Abstract][Full Text] [Related]
24. Autosomal recessive Alport syndrome: an in-depth clinical and molecular analysis of five families.
Longo I; Scala E; Mari F; Caselli R; Pescucci C; Mencarelli MA; Speciale C; Giani M; Bresin E; Caringella DA; Borochowitz ZU; Siriwardena K; Winship I; Renieri A; Meloni I
Nephrol Dial Transplant; 2006 Mar; 21(3):665-71. PubMed ID: 16338941
[TBL] [Abstract][Full Text] [Related]
25. Identification of 47 novel mutations in patients with Alport syndrome and thin basement membrane nephropathy.
Weber S; Strasser K; Rath S; Kittke A; Beicht S; Alberer M; Lange-Sperandio B; Hoyer PF; Benz MR; Ponsel S; Weber LT; Klein HG; Hoefele J
Pediatr Nephrol; 2016 Jun; 31(6):941-55. PubMed ID: 26809805
[TBL] [Abstract][Full Text] [Related]
26. How to resolve confusion in the clinical setting for the diagnosis of heterozygous COL4A3 or COL4A4 gene variants? Discussion and suggestions from nephrologists.
Imafuku A; Nozu K; Sawa N; Nakanishi K; Ubara Y
Clin Exp Nephrol; 2020 Aug; 24(8):651-656. PubMed ID: 32232700
[TBL] [Abstract][Full Text] [Related]
27. Female X-linked Alport syndrome with somatic mosaicism.
Yokota K; Nozu K; Minamikawa S; Yamamura T; Nakanishi K; Kaneda H; Hamada R; Nozu Y; Shono A; Ninchoji T; Morisada N; Ishimori S; Fujimura J; Horinouchi T; Kaito H; Nakanishi K; Morioka I; Taniguchi-Ikeda M; Iijima K
Clin Exp Nephrol; 2017 Oct; 21(5):877-883. PubMed ID: 27796712
[TBL] [Abstract][Full Text] [Related]
28. Retrospective genetic analysis illustrates the spectrum of autosomal Alport syndrome in a case of living-related donor kidney transplantation.
Petzold F; Bachmann A; Bergmann C; Helmchen U; Halbritter J
BMC Nephrol; 2019 Sep; 20(1):340. PubMed ID: 31477057
[TBL] [Abstract][Full Text] [Related]
29. Genetic and molecular dynamics analysis of two variants of the COL4A5 gene causing Alport syndrome.
Liang L; Wu H; Cai Z; Zhao J
BMC Med Genomics; 2023 Aug; 16(1):192. PubMed ID: 37596645
[TBL] [Abstract][Full Text] [Related]
30. Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome.
Marcocci E; Uliana V; Bruttini M; Artuso R; Silengo MC; Zerial M; Bergesio F; Amoroso A; Savoldi S; Pennesi M; Giachino D; Rombolà G; Fogazzi GB; Rosatelli C; Martinhago CD; Carmellini M; Mancini R; Di Costanzo G; Longo I; Renieri A; Mari F
Nephrol Dial Transplant; 2009 May; 24(5):1464-71. PubMed ID: 19129241
[TBL] [Abstract][Full Text] [Related]
31. Successful renal transplantation in a family with a novel mutation in COL4A3 gene and autosomal recessive Alport syndrome.
Girimaji N; Murugan Sm S; Nada R; Sharma A; Rathi M; Kohli HS; Gupta KL; Ramachandran R
Nephrology (Carlton); 2020 Jun; 25(6):497-501. PubMed ID: 31925849
[TBL] [Abstract][Full Text] [Related]
32. [Alport syndrome: Hereditary nephropathy associated with mutations in genes coding for type IV collagen chains].
Heidet L; Gubler MC
Nephrol Ther; 2016 Dec; 12(7):544-551. PubMed ID: 27816395
[TBL] [Abstract][Full Text] [Related]
33. Alport syndrome: deducing the mode of inheritance from the presence of haematuria in family members.
Savige J
Pediatr Nephrol; 2020 Jan; 35(1):59-66. PubMed ID: 30506145
[TBL] [Abstract][Full Text] [Related]
34. Renal, auricular, and ocular outcomes of Alport syndrome and their current management.
Zhang Y; Ding J
Pediatr Nephrol; 2018 Aug; 33(8):1309-1316. PubMed ID: 28864840
[TBL] [Abstract][Full Text] [Related]
35. A new mutation in the COL4A3 gene responsible for autosomal dominant Alport syndrome, which only generates hearing loss in some carriers.
Rosado C; Bueno E; Fraile P; García-Cosmes P; González-Sarmiento R
Eur J Med Genet; 2015 Jan; 58(1):35-8. PubMed ID: 25450602
[TBL] [Abstract][Full Text] [Related]
36. Deciphering the pathogenesis of the COL4-related hematuric nephritis: A genotype/phenotype study.
Uliana V; Sebastio P; Riva M; Carli D; Ruberto C; Bianchi L; Graziano C; Capelli I; Faletra F; Pillon R; Mattina T; Sensi A; Bonatti F; Percesepe A
Mol Genet Genomic Med; 2021 Feb; 9(2):e1576. PubMed ID: 33369211
[TBL] [Abstract][Full Text] [Related]
37. COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome.
Longo I; Porcedda P; Mari F; Giachino D; Meloni I; Deplano C; Brusco A; Bosio M; Massella L; Lavoratti G; Roccatello D; Frascá G; Mazzucco G; Muda AO; Conti M; Fasciolo F; Arrondel C; Heidet L; Renieri A; De Marchi M
Kidney Int; 2002 Jun; 61(6):1947-56. PubMed ID: 12028435
[TBL] [Abstract][Full Text] [Related]
38. A novel COL4A3 mutation causes autosomal-recessive Alport syndrome in a large Turkish family.
Uzak AS; Tokgoz B; Dundar M; Tekin M
Genet Test Mol Biomarkers; 2013 Mar; 17(3):260-4. PubMed ID: 23297803
[TBL] [Abstract][Full Text] [Related]
39. Genotype-phenotype correlation and prognostic impact in Chinese patients with Alport Syndrome.
Shang S; Peng F; Wang T; Wu X; Li P; Li Q; Chen XM
Mol Genet Genomic Med; 2019 Jul; 7(7):e00741. PubMed ID: 31144478
[TBL] [Abstract][Full Text] [Related]
40. Women and Alport syndrome.
Rheault MN
Pediatr Nephrol; 2012 Jan; 27(1):41-6. PubMed ID: 21380623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
